维普期刊资源整合服务平台（V6.5）

60篇 您的检索式：作者名="Berthold I"

选中清除导出查看参考文献查看引证文献引用追踪共3页首页上一页第1页下一页末页 /3 跳转

	题名	作者	年代	出处	被引量
1	维生素D对心力衰竭患者全因死亡率的影响:4000U/d维生素D口服3年随机临床试验结果显示文摘循环25-羟基维生素D[25-hydroxyvitamin D,25(OH)D]〈75nmol/L与死亡率风险的非线性增加相关。这种低25(OH)D水平在心力衰竭患者中很常见。因此,Zittermann等进行研究检查口服维生素D补充剂能否降低晚期心力衰竭患者的死亡率。	刘莉叶鹏 Zittermann A Ernst JB Prokop S Fuchs U Dreier J Kuhn J Knabbe C Birschmann I Schulz U Berthold HK Pilz S Gouni-Berthold I Gummert JF Dittrich M Brgermann J	2017	中华高血压杂志2017，25，10：	7
2	PCSK9 antibodies for the treatment of hypercholesterolemia显示文摘	GOUNI-BERTHOLD I BERTHOLD HK	2014	Nutrients2014，6，12：	1
3	Policosanol:Clinical pharmacology and therapeutic significance of a new lipid-lowing agent显示文摘	GOUNI-BERTHOLD I BERTHOLD H K	2002	Am Heart J2002，143，2：	1
4	Immunogenicity in mice of anthrax recombinant protective antigen in the presence of aluminum adjuvants 显示文摘	Berthold I Pombo ML Wagner L et ol	2005	Vaccine2005，23，6：	1
5	Lipoprotein(a):Current perspectives显示文摘	Gouni-Berthold I Berthold HK	2011	Curr Vasc Pharmacol2011，9，6：	1
6	The whey fermentation product malleable protein matrix decreases TAG concentrations in patients with the metabolic syndrome : a randomised placebo - controlled trial 显示文摘	Gouni- Berthold I Schulte DM Krone W	2012	The British journal of nutrition2012，107，11：	1
7	Troglitazone and msiglitazone inhibit the low density lipoprotein-induced vascular smooth muscle cell growth显示文摘	Gouni-Berthold I Berthold HK Weber AA	2001	Exp Clin Endocrinol Diabetes2001，109，4：	1
8	Longer versus shorter daily constraint-induced movement therapy of chronic hemiparesis:an exploratory study显示文摘	Sterr A Elbert T Berthold I	2002	Arch Phys Med Rehabil2002，83，10：	1
9	Novel pyrogen tests based on the human fever reaction-the report and recommendations of ecvam workshop显示文摘	Hartung T Aaberge I Berthold S	2001	Alter Lab Anim2001，29，2：	1
10	Effects of lipid-lowering drugs on irisin in human subjects in vivo and in human skeletal muscle cells ex vivo显示文摘	Gouni-Berthold I Berthold HK Huh JY	2013	PLo S One2013，8，72：	1
11	Lipoprotein(a):current perspectives显示文摘	Gouni-Berthold I Berthold HK		0，，06：	1
12	Skin sensitization testing in potency and risk assessment 显示文摘	Kimber I Basketter DA Berthold K	2001	Toxicol Sci2001，59，2：	1
13	Lipid-lowering drug therapy in elderly patients显示文摘	Berthold HK Gouni-Berthold I	2011	Curr Pharm Des2011，17，9：	1
14	Longer versus shorter daily con- sWaint-induced movement therapy of chronic hemiparesis: an ex- ploratory study显示文摘	Sterr A Elbert T Berthold I	2002	Arch Phys Med Rehabil2002，83，10：	1
15	Polieosanol: clinical pharmacology and therapeutic significance of a new lipid-lowering agent 显示文摘	Gouni-Berthold I Berthold HK	2002	Am Heart J2002，143，2：	1
16	Longer versus shorter daily constraint-induced movement therapy of chronic hemi- paresis: an exploratory study显示文摘	Sterr A Elbert T Berthold I	2002	Arch Phys Med Rehahil2002，83，10：	1
17	Effects of ezetimibe and/or simvastatin on LDL receptor protein expression and on LDL receptor and HMG-CoA reductase gene expression: a randomized trial in healthy men 显示文摘	GOUNI-BERTHOLD I BERTHOLD H K GYLLING H	2008	Atherosclerosis2008，198，1：	1
18	Policosanol:clinical pharmacology and therapeutic significance of a new lipid-lowering agent 显示文摘	GOUNI-BERTHOLD I BERTHOLD HK	2002	Am Heart J2002，143，2：	1
19	Effects of lipid- lowering drugs on irisin in human subjects in vivo and in human skeletal muscle ceils ex vivo 显示文摘	Gouni-Berthold I Berthold HK Huh JY	2013	PLoS One2013，8，72：	1
20	Policosanol pharmacology and therapeutic significance of a new lipid-lowering agent 显示文摘	Gouni-Berthold I Berthold HK	2002	Am Heart J2002，143，2：	1

返回顶部每页显示：

共3页首页上一页第1页下一页末页 /3 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示